Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
<strong>Background:</strong> Blood biomarkers may aid in recruitment to clinical trials of Alzheimer’s disease (AD) modifying therapeutics by triaging potential trials participants for amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) Aβ and tau tests. <strong&g...
Những tác giả chính: | Westwood, S, Baird, AL, Hye, A, Ashton, NJ, Nevado-Holgado, AJ, Anand, SN, Liu, B, Newby, D, Bazenet, C, Kiddle, SJ, Ward, M, Newton, B, Desai, K, Hehir, C, Zanette, M, Galimberti, D, Parnetti, L, Lleó, A, Baker, S, Narayan, VA, Van Der Flier, WM, Scheltens, P, Teunissen, CE, Visser, PJ, Lovestone, S |
---|---|
Định dạng: | Journal article |
Được phát hành: |
Frontiers Media
2018
|
Những quyển sách tương tự
-
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
Bằng: Sarah Westwood, et al.
Được phát hành: (2018-12-01) -
The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
Bằng: Westwood, S, et al.
Được phát hành: (2017) -
New CSF biomarkers on the block
Bằng: Charlotte E Teunissen, et al.
Được phát hành: (2016-09-01) -
Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
Bằng: Rosha Babapour Mofrad, et al.
Được phát hành: (2019-12-01) -
Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
Bằng: Nevado-Holgado, A, et al.
Được phát hành: (2016)